Hainan Hailing Cemipharma Corp.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Hainan Hailing Cemipharma Corp. Patents
Hainan Hailing Cemipharma Corp. has filed 2 patents.
The 3 most popular patent topics include:
- Bacterial diseases
- Cephalosporin antibiotics
- Chromatography
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/29/2021 | Cephalosporin antibiotics, Chromatography, Thiazoles, Phenols, Tetrazoles | Application |
Application Date | 12/29/2021 |
|---|---|
Grant Date | |
Title | |
Related Topics | Cephalosporin antibiotics, Chromatography, Thiazoles, Phenols, Tetrazoles |
Status | Application |
Hainan Hailing Cemipharma Corp. Frequently Asked Questions (FAQ)
Where is Hainan Hailing Cemipharma Corp.'s headquarters?
Hainan Hailing Cemipharma Corp.'s headquarters is located at 6 Jinyu Road, Haikou.
What is Hainan Hailing Cemipharma Corp.'s latest funding round?
Hainan Hailing Cemipharma Corp.'s latest funding round is Unattributed VC.
How much did Hainan Hailing Cemipharma Corp. raise?
Hainan Hailing Cemipharma Corp. raised a total of $17M.
Who are the investors of Hainan Hailing Cemipharma Corp.?
Investors of Hainan Hailing Cemipharma Corp. include AIF Captial and Mitsui & Co. Global Investment.
Who are Hainan Hailing Cemipharma Corp.'s competitors?
Competitors of Hainan Hailing Cemipharma Corp. include Neos Therapeutics, OcuNexus Therapeutics, GC-Rise Pharmaceutical, Peckforton Pharmaceuticals, Oceana Therapeutics and 13 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Hainan Hailing Cemipharma Corp. to Competitors
ISW Group is a pharmaceutical company that researches and aims to develop FDA approved topical products for the management and treatment of acute and chronic inflammatory skin conditions. ISW Group's research program focuses on acute and chronic dermatologic irritation and inflammation associated with dermatitis, Pseudofolliculitis barbae, burn care and wound healing.
QOL Medical is a specialty pharmaceutical company focused on the gastrointestinal market.
OcuNexus Therapeutics is a development stage biopharmaceutical company that develops treatments for front- and back-of-the-eye diseases and disorders.
Azur Pharma is a pharmaceutical company focused on the CNS, women's health and urology markets of the US.
A European specialty pharmaceutical company dedicated to hospital and specialist drugs.SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market.
Roxro Pharma is an early-stage specialty pharmaceutical company dedicated to identifying, licensing, and developing compounds in specialized disease areas with significant sales potential, such as pain management. Roxro will pursue product development with the objective of commercializing these products. Niche products will not be developed by major pharmaceutical companies because they will not fuel their growth requirements. Foreign and biotechnology companies with compounds that have a limited sales potential will not be partnered with major pharmaceutical companies. Therefore there are a number of products not being developed even though they are efficacious, safe and satisfy an unmet medical need.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
